Valuation: Orthofix Medical Inc.

Market Cap 395M 347M 320M 299M 561M 37.29B 573M 3.84B 1.49B 18.43B 1.48B 1.45B 63.91B P/E 2026 *
-8.05x
P/E 2027 * -9.68x
Enterprise Value 395M 347M 320M 299M 561M 37.29B 573M 3.84B 1.49B 18.43B 1.48B 1.45B 63.91B EV / Sales 2026 *
0.47x
EV / Sales 2027 * 0.45x
Free-Float
97.81%
Yield 2026 *
-
Yield 2027 * -
1 day+5.05%
1 week+3.49%
Current month+5.50%
1 month+3.06%
3 months-14.96%
6 months-35.83%
Current year-35.49%
1 week 8.85
Extreme 8.85
9.88
1 month 8.85
Extreme 8.85
10.58
Current year 8.85
Extreme 8.85
16.42
1 year 8.85
Extreme 8.85
16.99
3 years 8.85
Extreme 8.85
21.6
5 years 8.85
Extreme 8.85
43.3
10 years 8.85
Extreme 8.85
74.44
Manager TitleAgeSince
Chief Executive Officer 54 2024-01-07
Director of Finance/CFO 55 2024-01-14
Compliance Officer - 2015-01-31
Director TitleAgeSince
Director/Board Member 66 2016-03-15
Director/Board Member 54 2020-06-07
Director/Board Member 64 2023-01-04
Date Insider Type Main position Quantity % Market Cap.
06-17Sell

Executive/Senior Manager

-3,670 0.0091%
06-09Free

Director

14,965 0.0370%
06-09Free

Director

14,965 0.0370%
Change 5-day change 1-year change 3-year change Capi.($)
+5.05%+3.49%-11.81%-45.97% 395M
+0.94%+6.46%-29.96%-12.54% 164B
+1.48%+2.07%-5.86%-6.23% 104B
-0.29%+5.26%-4.44%+50.82% 55.67B
-1.06%-6.06%+47.71%+50.03% 52.92B
+3.00%+8.29%-8.74%-39.80% 42.96B
+2.91%+8.15% - - 32.87B
+2.17%-3.22%-18.75%-44.52% 27.07B
+1.24%+6.98%+60.30%-4.97% 24.79B
+2.41%+6.45%-9.68%-0.56% 21.02B
Average +1.80%+3.78%+2.08%-5.97% 52.53B
Weighted average by Cap. +1.16%+3.98%-5.76%-0.59%

Financials

2026 *2027 *
Net sales 841M 738M 680M 637M 1.19B 79.36B 1.22B 8.17B 3.16B 39.22B 3.16B 3.09B 136B 881M 773M 712M 667M 1.25B 83.15B 1.28B 8.56B 3.31B 41.1B 3.31B 3.24B 143B
Net income -47.49M -41.64M -38.38M -35.93M -67.38M -4.48B -68.78M -461M -179M -2.21B -178M -174M -7.68B -40.38M -35.4M -32.63M -30.55M -57.29M -3.81B -58.48M -392M -152M -1.88B -152M -148M -6.53B
Net Debt - -
Logo Orthofix Medical Inc.
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Employees
1,605
Date Price Change Volume
26-06-26 US$9.780 +5.05% 1,082,610
26-06-25 US$9.310 -0.53% 247,379
26-06-24 US$9.360 +2.86% 333,035
26-06-23 US$9.100 +1.68% 337,121
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
9.780USD
Average target price
15.00USD
Spread / Average Target
+53.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. OFIX Stock